Should Patients With “Low Disease Activity” Rheumatoid Arthritis Stop Using Tumor Necrosis Factor Inhibitor Drugs?

New evidence provides more information to help physicians and patients make the decision.

Tumor necrosis factor inhibitor drugs (TNFi) are biologic agents used worldwide, known to be effective in the treatment of inflammatory conditions such as rheumatoid arthritis (RA), and also such conditions as psoriatic arthritis, juvenile arthritis, inflammatory bowel disease and ankylosing spondylitis. The drugs can reduce inflammation and stop disease progression. However, they are expensive and […]

Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×